Association of Hemostasis and Folate Cycle Gene Polymorphisms with Central and Branch Retinal Vein Occlusions: A Case-Control Study
DOI:
https://doi.org/10.48048/tis.2026.11483Keywords:
Hemostasis genes, Folate cycle genes, Retinal vein occlusions, Genetic polymorphisms, Hemostasis genes, Folate cycle genes, CRVO, BRVO, PCR-RFLPAbstract
Retinal vein occlusions, including CRVO and BRVO, are significant causes of visual impairment, with various systemic and genetic factors influencing their development. This study investigates the hemodynamic parameters and genetic polymorphisms of genes of hemostasis and the folate cycle in patients with RVO.A case-control study involved 51 retinal vein occlusion patients and 57 controls. Clinical evaluation was performed through optical coherence tomography and color duplex mapping. Genetic analysis was carried out using polymerase chain reaction-restriction fragment length polymorphism to detect polymorphisms in PAI1, ITGA2, F7, F13, MTRR, and MTHFR genes. Visual acuity was significantly reduced in central retinal vein occlusion (CRVO: 0.4 [0.0 - 0.9], 0.50.4) and branch retinal vein occlusion (BRVO: 0.45 [0.0 - 1.0], 0.50.2) compared to controls (0.9 [0.7 - 1.0], 0.10.6). Optical coherence tomography showed increased retinal thickness in BRVO (p < 0.0001). Hemodynamic analysis revealed reduced ocular blood flow velocities (BRVO: −59.0%, 95% CI: 50.0 - 68.0; CRVO: −53.6%, 95% CI: 44.2 - 63.0; p < 0.0001). Genetic testing identified strong associations between RVO and PAI1 (OR = 2.31, 95% CI: 1.34 - 3.12), ITGA2 (OR = 2.15, 95% CI: 1.27 - 2.89), F7 (OR = 1.98, 95% CI: 1.21 - 2.71), F13 (OR = 2.20, 95% CI: 1.28 - 3.02), MTRR (OR = 1.87, 95% CI: 1.13 - 2.59), and MTHFR (OR = 2.56, 95% CI: 1.48 - 3.42). Logistic regression, adjusted for hypertension and diabetes, confirmed these genetic variants as independent RVO risk factors. These findings suggest that genetic testing with polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) can help detect these polymorphisms early. This may support timely diagnosis and management of retinal vein occlusion (RVO), leading to more personalized care and better outcomes.
HIGHLIGHTS
- This study identifies significant associations between retinal vein occlusion (RVO) and genetic polymorphisms in plasminogen activator inhibitor-1 (PAI1), integrin subunit alpha 2 (ITGA2), coagulation factor VII (F7), coagulation factor XIII (F13), methionine synthase reductase (MTRR), and methylenetetrahydrofolate reductase (MTHFR).
- A strong correlation was found between macular thickness, ocular blood flow, and specific genetic variants in patients with RVO.
- PCR-RFLP-based genetic screening shows promise for early diagnosis and individualized risk assessment in retinal vascular disorders.
GRAPHICAL ABSTRACT
Downloads
References
EV Kabardina and IP Shurygina. Contemporary view of retinal vein thromboses. Kuban Scientific Medical Bulletin 2019; 26(1), 187-195.
M Lendzioszek, A Bryl, E Poppe, K Zorena and M Mrugacz. Retinal vein occlusion-background knowledge and foreground knowledge prospects: A review. Journal of Clinical Medicine 2024; 13(13), 3950.
SL Tejado, CM Acebal, CB Morales, S Alforja and JZ Ventura. Central retinal vein occlusion. In: J Chhablani (Ed.). Retinal and choroidal vascular diseases of the eye. 1st ed. Academic Press, Amsterdam, Netherlands, 2024, p. 165-177.
S Qu, Y Zou, L Yang and H Wu. The progress of assessment methods and treatments of neovascular glaucoma secondary to central retinal vein occlusion. Frontiers in Medicine 2024; 10(2024), 1280776.
CY Bakhoum, S Madala, CK Long, F Adabifirouzjaei, WR Freeman, MH Goldbaum, AN DeMaria and MF Bakhoum. Retinal vein occlusion is associated with stroke independent of underlying cardiovascular disease. Eye 2023; 37(4), 764-767.
Q Ghadiali, LK Ghadiali and LA Yannuzzi. Bartonella henselae neuroretinitis associated with central retinal vein occlusion, choroidal ischemia, and ischemic optic neuropathy. Retinal Cases and Brief Reports 2020; 14(1), 23-26.
R Zeng, I Garg, D Bannai, M Kasetty, R Katz, JY Park, P Lizano and JB Miller. Retinal microvasculature and vasoreactivity changes in hypertension using optical coherence tomography-angiography. Graefe’s Archive for Clinical and Experimental Ophthalmology 2022; 260(11), 3505-3515.
JF Chiang, MH Sun, KJ Chen, WC Wu, CC Lai, CJ Chang, YJ Lin, SC Chang, HY Huang, NH Chen and HY Li. Association between obstructive sleep apnea and diabetic macular edema in patients with type 2 diabetes. American Journal of Ophthalmology 2021; 226, 217-225.
G Casalino, KN Khan, M Armengol, G Wright, N Pontikos, M Georgiou, AR Webster, AG Robson, PS Grewal and M Michaelides. Autosomal recessive bestrophinopathy: Clinical features, natural history, and genetic findings in preparation for clinical trials. Ophthalmology 2021; 128(5), 706-718.
F Hajer, S Hana, C Saoussen, F Abdelhak, B Nadia, D Ameni, G Habib, BA Hassen and HK Amel. Genetic polymorphisms in VEGFA and VEGFR2 genes associated with coronary heart disease susceptibility and severity. Molecular Biology Reports 2023; 50(12), 10169-10177.
JJN Lecumberri, PG Bores, AC Marín, FAC Avendaño, JMO Martínez and JL Hernández. Lipid profile and serum folate, vitamin B12 and homocysteine levels in patients with retinal vein occlusion. Clínica e Investigación en Arteriosclerosis 2021; 33(4), 169-174.
I Borodina, G Salavatova and L Shardina. Polymorphisms of F2 (G20210A), F5 (G1691A), F7 (G10976A), F13 (G13T), FGB, ITGA2, ITGB3, PAI-I genes and its association with thrombotic complications in patients suffering from Takayasu aortoarteritis of Urals population. Turk Kardiyoloji Dernegi Arsivi: Turk Kardiyoloji Derneginin Yayin Organidir 2021; 49(6), 448-455.
PR Ames, A Arcaro, G D’Andrea, V Marottoli, L Iannaccone, M Maraglione and F Gentile. Homozygous MTHFR C667T carriers ≤ 45 years old develop central retinal vein occlusion five years earlier than wild type. Ophthalmic Genetics 2024; 45(4), 378-383.
T Kogo, Y Muraoka, Y Iida, S Ooto, T Murakami, S Kadomoto, Y Iida-Miwa, S Numa, M Miyake, M Miyata, A Uji and A Tsujikawa. Angiographic risk features of branch retinal vein occlusion onset as determined by optical coherence tomography angiography. Investigative Ophthalmology & Visual Science 2020; 61(2), 8.
J Maiuolo, F Oppedisano, C Carresi, M Gliozzi, V Musolino, R Macrì, F Scarano, A Coppoletta, A Cardamone, F Bosco, R Mollace, C Muscoli, E Palma and V Mollace. The generation of nitric oxide from aldehyde dehydrogenase-2: The role of dietary nitrates and their implication in cardiovascular disease management. International Journal of Molecular Sciences 2022; 23(24), 15454.
J Shi, HV Danesh-Meyer and MT Bhatti. Neuroretinitis: A comprehensive review on aetiologies, clinical manifestations, and treatment options. Eye 2025; 39(2), 238-250.
C Yuan, C He, L Zuo, B Liu and H Qi. The effect of coagulation traits on the risk of retinal vein occlusion: A Mendelian randomization study. Scientific Reports 2025; 15(1), 3052.
HJ Kim, YU Shin, Y Lee, MH Kang, M Seong, H Cho, R Heo, JK Park, YH Lim and JH Shin. Increasing incidence of macular edema in excessive morning blood pressure surge in patients with retinal vein occlusion. Scientific Reports 2020; 10(1), 4420.
WH Lee, JH Park, Y Won, MW Lee, YI Shin, YJ Jo and JY Kim. Retinal microvascular change in hypertension as measured by optical coherence tomography angiography. Scientific Reports 2019; 9(1), 156.
YY Koh, CC Lai, WC Wu, YS Hwang, KJ Chen, NK Wang, TL Chen, JC Huang, L Liu and L Yeung. Baseline clinical features predict visual outcome in young patients with central retinal vein occlusion. Graefe’s Archive for Clinical and Experimental Ophthalmology 2020; 258(7), 1367-1377.
L Koklesova, A Mazurakova, M Samec, K Biringer, SM Samuel, D Büsselberg, P Kubatka and O Golubnitschaja. Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person. EPMA Journal 2021; 12(4), 477-505.
MM Eldibany and JA Caprini. Hyperhomocysteinemia and thrombosis: An overview. Archives of Pathology & Laboratory Medicine 2007; 131(6), 872-884.
A Babi, T Issa, A Gusmanov, A Akilzhanova, A Issanov, N Makhmetova, A Marat, Y Iztleuov and G Aimagambetova. Prevalence of high-risk human papillomavirus infection and genotype distribution among Kazakhstani women with abnormal cervical cytology. Annals of Medicine 2024; 56(1), 2304649.
R Koch, B Seto, K Yamada, P Atreay, CA Lemire, N Hazra and JG Arroyo. Relative retinal blood flow: A novel and informative measure of unilateral retinal vein occlusion severity. Translational Vision Science & Technology 2021; 10(3), 15.
Q Wei, W Qiu, Q Liu and Y Jiang. Relationship between risk factors and macular thickness in patients with early diabetic retinopathy. International Journal of General Medicine 2022; 15, 6021-6029.
M Wu, H Xiong, Y Xu, X Xiong, H Zou, M Zheng, X Wang and X Zhou. Association between VEGF-A and VEGFR-2 polymorphisms and response to treatment of neovascular AMD with anti-VEGF agents: A meta-analysis. British Journal of Ophthalmology 2017; 101(7), 976-984.
M Ørskov, H Vorum, T Bjerregaard Larsen, N Vestergaard, GYH Lip, T Bek and F Skjøth. A review of risk factors for retinal vein occlusions. Expert Review of Cardiovascular Therapy 2022; 20(9), 761-772.
CY Wu, T Riangwiwat, N Limpruttidham, P Rattanawong, RB Rosen and A Deobhakta. Association of retinal vein occlusion with cardiovascular events and mortality: A systematic review and meta-analysis. Retina 2019; 39(9), 1635-1645.
AL Rothman, AS Thomas, K Khan and S Fekrat. Central retinal vein occlusion in young individuals: A comparison of risk factors and clinical outcomes. Retina 2019; 39(10), 1917-1924.
N Dervenis, P Dervenis and E Agorogiannis. Neovascular age-related macular degeneration: Disease pathogenesis and current state of molecular biomarkers predicting treatment response: A scoping review. BMJ Open Ophthalmology 2024; 9(1), e001516.
M Marques, F Alves, M Leitão, C Rodrigues and JT Ferreira. Methylenetetrahydrofolate reductase polymorphisms as risk factors for retinal venous occlusive disease: A literature review. European Journal of Ophthalmology 2021; 31(3), 884-891.
Published
Issue
Section
License
Copyright (c) 2025 Walailak University
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
